Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease

IntroductionPercutaneous transluminal renal angioplasty (PTRA) fails to fully improve cardiac injury and dysfunction in patients with renovascular hypertension (RVH). Mesenchymal stem cells (MSCs) restore renal function, but their potential for attenuating cardiac injury after reversal of RVH has not been explored. We hypothesized that replenishment of MSCs during PTRA would improve cardiac function and oxygenation, and decrease myocardial injury in porcine RVH.MethodsPigs were studied after 16 weeks of RVH, RVH treated 4 weeks earlier with PTRA with or without adjunct intra-renal delivery of MSC (10^6 cells), and controls. Cardiac structure, function (fast-computed tomography (CT)), and myocardial oxygenation (Blood-Oxygen-Level-Dependent- magnetic resonance imaging) were assessed in-vivo. Myocardial microvascular density (micro-CT) and myocardial injury were evaluated ex-vivo. Kidney venous and systemic blood levels of inflammatory markers were measured and their renal release calculated.ResultsPTRA normalized blood pressure, yet stenotic-kidney glomerular filtration rate, similarly blunted in RVH and RVH + PTRA, normalized only in PTRA + MSC-treated pigs. PTRA attenuated left ventricular remodeling, whereas myocardial oxygenation, subendocardial microvascular density, and diastolic function remained decreased in RVH + PTRA, but normalized in RVH + PTRA-MSC. Circulating isoprostane levels and renal release of inflammatory cytokines increased in RVH and RVH + PTRA, but normalized in RVH + PTRA-MSC, as did myocardial oxidative stress, inflammation, collagen deposition, and fibrosis.ConclusionsIntra-renal MSC delivery during PTRA preserved stenotic-kidney function, reduced systemic oxidative stress and inflammation, and thereby improved cardiac function, oxygenation, and myocardial injury four weeks after revascularization, suggesting a therapeutic potential for adjunctive MSC delivery to preserve cardiac function and structure after reversal of experimental RVH.

[1]  L. Lerman,et al.  Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension , 2014, Journal of hypertension.

[2]  N. Mariappan,et al.  TNF-alpha-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. , 2007, American journal of physiology. Heart and circulatory physiology.

[3]  E. Ritman,et al.  Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. , 2007, Journal of the American Society of Nephrology : JASN.

[4]  R. Lavi,et al.  Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular Disease , 2009, Circulation.

[5]  L. Lerman,et al.  Cardiac function in renovascular hypertensive patients with and without renal dysfunction. , 2014, American journal of hypertension.

[6]  C. Long.  The Role of Interleukin-1 in the Failing Heart , 2001, Heart Failure Reviews.

[7]  P. Kalra,et al.  The heart in atherosclerotic renovascular disease. , 2012, Frontiers in bioscience.

[8]  L. Lerman,et al.  Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction. , 2011, American journal of physiology. Heart and circulatory physiology.

[9]  C. Napoli,et al.  Role of Oxidative Stress in Remodeling of the Myocardial Microcirculation in Hypertension , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[10]  L. Lerman,et al.  Comparison of acute and chronic antioxidant interventions in experimental renovascular disease. , 2004, American journal of physiology. Renal physiology.

[11]  S. Perez,et al.  Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells , 2006, Stem cells.

[12]  L. Lerman,et al.  Changes in Glomerular Filtration Rate After Renal Revascularization Correlate With Microvascular Hemodynamics and Inflammation in Swine Renal Artery Stenosis , 2012, Circulation. Cardiovascular interventions.

[13]  L. Lerman,et al.  A Mitochondrial Permeability Transition Pore Inhibitor Improves Renal Outcomes After Revascularization in Experimental Atherosclerotic Renal Artery Stenosis , 2012, Hypertension.

[14]  A. Flake,et al.  Mesenchymal stem cells: paradoxes of passaging. , 2004, Experimental hematology.

[15]  L. Lerman,et al.  MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells. , 2014, Gene.

[16]  E. Ritman,et al.  Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT. , 2007, Radiology.

[17]  R. Dmitrieva,et al.  The effect of bone marrow‐ and adipose tissue‐derived mesenchymal stem cell transplantation on myocardial remodelling in the rat model of ischaemic heart failure , 2013, International journal of experimental pathology.

[18]  C. Napoli,et al.  Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. , 2003, Cardiovascular research.

[19]  L. Lerman,et al.  Endothelial Outgrowth Cells Shift Macrophage Phenotype and Improve Kidney Viability in Swine Renal Artery Stenosis , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[20]  C. Napoli,et al.  Mechanisms of Renal Structural Alterations in Combined Hypercholesterolemia and Renal Artery Stenosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R. Lavi,et al.  Monocyte Chemoattractant Proteins Mediate Myocardial Microvascular Dysfunction in Swine Renovascular Hypertension , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[22]  A. Harken,et al.  Interleukin 1 pretreatment decreases ischemia/reperfusion injury. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Fuchs,et al.  Crucial Role of Interferon-γ and Stimulated Macrophages in Cardiovascular Disease , 2006 .

[24]  N. Danchin,et al.  Association of IL1B polymorphism with left ventricular systolic dysfunction: a relation with the release of interleukin-1&bgr; in stress condition , 2011, Pharmacogenetics and genomics.

[25]  L. Lerman,et al.  Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease. , 2012, Atherosclerosis.

[26]  F. Reinholt,et al.  Intramyocardial Injections of Human Mesenchymal Stem Cells following Acute Myocardial Infarction Modulate Scar Formation and Improve Left Ventricular Function , 2012, Cell transplantation.

[27]  L. Lerman,et al.  Mesenchymal Stem Cells Improve Medullary Inflammation and Fibrosis after Revascularization of Swine Atherosclerotic Renal Artery Stenosis , 2013, PloS one.

[28]  D. Goldfarb.  Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996-2000. , 2005, The Journal of urology.

[29]  L. Lerman,et al.  Mesenchymal Stem Cells and Endothelial Progenitor Cells Decrease Renal Injury in Experimental Swine Renal Artery Stenosis Through Different Mechanisms , 2013, Stem cells.

[30]  J. D. de Fijter,et al.  Mesenchymal stromal cell therapy for cardio renal disorders. , 2014, Current pharmaceutical design.

[31]  C. Napoli,et al.  Distinct Renal Injury in Early Atherosclerosis and Renovascular Disease , 2002, Circulation.

[32]  M. Rossi,et al.  Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. , 2013, Experimental and molecular pathology.

[33]  L. Lerman,et al.  Inflammatory and injury signals released from the post-stenotic human kidney. , 2013, European heart journal.

[34]  G. Lip,et al.  Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. , 2006, The American journal of cardiology.

[35]  B. Baradaran,et al.  Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy. , 2014, Advanced pharmaceutical bulletin.

[36]  E. Ritman,et al.  Cortical Microvascular Remodeling in the Stenotic Kidney: Role of Increased Oxidative Stress , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[37]  L. Lerman,et al.  Reversal of experimental renovascular hypertension restores coronary microvascular function and architecture. , 2011, American journal of hypertension.

[38]  Ralph B D'Agostino,et al.  Stenting and medical therapy for atherosclerotic renal-artery stenosis. , 2014, The New England journal of medicine.

[39]  I. Pipinos,et al.  Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis. , 1998, Journal of vascular surgery.

[40]  C. Napoli,et al.  Antioxidant intervention blunts renal injury in experimental renovascular disease. , 2004, Journal of the American Society of Nephrology : JASN.

[41]  L. Lerman,et al.  Obesity-metabolic derangement exacerbates cardiomyocyte loss distal to moderate coronary artery stenosis in pigs without affecting global cardiac function. , 2014, American journal of physiology. Heart and circulatory physiology.

[42]  Claudio Napoli,et al.  Antioxidant Intervention Attenuates Myocardial Neovascularization in Hypercholesterolemia , 2004, Circulation.

[43]  B. Kromer,et al.  Coronary artery constriction by the isoprostane 8‐epi prostaglandin F2α , 1996, British journal of pharmacology.

[44]  C. Napoli,et al.  The FASEB Journal • FJ Express Full-Length Article Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia , 2022 .

[45]  A. Dietz,et al.  Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  L. Lerman,et al.  Adipose Tissue‐Derived Mesenchymal Stem Cells Improve Revascularization Outcomes to Restore Renal Function in Swine Atherosclerotic Renal Artery Stenosis , 2012, Stem cells.

[47]  R. Lavi,et al.  Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. , 2008, Life sciences.

[48]  L. Lerman,et al.  Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension , 2014, Journal of hypertension.

[49]  D. Fuchs,et al.  Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease. , 2006, Current vascular pharmacology.

[50]  L. Lerman,et al.  Stent Revascularization Restores Cortical Blood Flow and Reverses Tissue Hypoxia in Atherosclerotic Renal Artery Stenosis but Fails to Reverse Inflammatory Pathways or Glomerular Filtration Rate , 2013, Circulation. Cardiovascular interventions.